IRIS
RUSSO, CINZIA VALERIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.630
AS - Asia 3.612
EU - Europa 2.530
SA - Sud America 431
Continente sconosciuto - Info sul continente non disponibili 226
AF - Africa 111
OC - Oceania 5
Totale 10.545
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.483
SG - Singapore 1.522
RU - Federazione Russa 1.133
CN - Cina 687
VN - Vietnam 653
IT - Italia 533
BR - Brasile 326
HK - Hong Kong 321
DE - Germania 171
NL - Olanda 142
FR - Francia 129
GB - Regno Unito 98
CA - Canada 80
FI - Finlandia 77
IN - India 68
UA - Ucraina 62
BD - Bangladesh 52
JP - Giappone 51
AR - Argentina 50
IE - Irlanda 50
IR - Iran 43
KR - Corea 33
ZA - Sudafrica 33
CI - Costa d'Avorio 29
MX - Messico 29
PH - Filippine 24
AT - Austria 22
TH - Thailandia 22
ES - Italia 20
PL - Polonia 20
TR - Turchia 18
IQ - Iraq 17
PK - Pakistan 15
SE - Svezia 15
EC - Ecuador 13
ID - Indonesia 12
VE - Venezuela 12
LT - Lituania 11
BG - Bulgaria 10
TN - Tunisia 10
JM - Giamaica 8
TW - Taiwan 8
AE - Emirati Arabi Uniti 7
CL - Cile 7
CR - Costa Rica 7
JO - Giordania 7
NP - Nepal 7
BO - Bolivia 6
CO - Colombia 6
EG - Egitto 6
MY - Malesia 6
NI - Nicaragua 6
SA - Arabia Saudita 6
UY - Uruguay 6
AZ - Azerbaigian 5
BE - Belgio 5
KE - Kenya 5
UZ - Uzbekistan 5
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
ET - Etiopia 4
KW - Kuwait 4
LB - Libano 4
RS - Serbia 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
DZ - Algeria 3
MA - Marocco 3
MN - Mongolia 3
MU - Mauritius 3
SN - Senegal 3
BB - Barbados 2
BZ - Belize 2
CG - Congo 2
EE - Estonia 2
GR - Grecia 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
MT - Malta 2
PE - Perù 2
RE - Reunion 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AW - Aruba 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GE - Georgia 1
GF - Guiana Francese 1
GH - Ghana 1
Totale 10.298
Salva come PNG Salva come JPEG
Città #
Singapore 766
San Jose 623
Ashburn 343
Hong Kong 299
Moscow 283
Chandler 278
Beijing 199
Ho Chi Minh City 196
Santa Clara 156
Hefei 154
Hanoi 144
Amsterdam 119
Los Angeles 94
Naples 92
Council Bluffs 90
Lauterbourg 74
Dallas 71
Millbury 64
New York 57
The Dalles 54
Napoli 52
Des Moines 47
Nanjing 45
Tokyo 43
Princeton 40
Rome 40
Munich 35
Phoenix 35
São Paulo 35
Boston 34
Buffalo 32
Redondo Beach 32
Houston 27
London 27
Seattle 27
Frankfurt am Main 26
Chicago 25
Da Nang 25
Seoul 25
Denver 23
Lawrence 23
Montreal 23
Haiphong 22
Norwalk 22
Nuremberg 22
Wilmington 22
Helsinki 21
Turku 20
Warsaw 20
Toronto 19
Johannesburg 18
Milan 17
Orem 16
Brooklyn 15
Atlanta 14
Ottawa 13
Poplar 13
Pune 13
San Francisco 13
Tianjin 13
Vienna 13
Cava De' Tirreni 12
Dong Ket 12
Dublin 12
Falkenstein 12
Can Tho 11
Rio de Janeiro 11
Belo Horizonte 10
Biên Hòa 10
Nanchang 9
Redwood City 9
Sofia 9
Ankara 8
Chennai 8
Jacksonville 8
Manchester 8
Paris 8
Bangkok 7
Boardman 7
Fairfield 7
Hải Dương 7
Milwaukee 7
New Delhi 7
Porto Alegre 7
Quận Bình Thạnh 7
Shenyang 7
Stockholm 7
Washington 7
Amman 6
Caracas 6
Curitiba 6
Ha Long 6
Kingston 6
Kronberg 6
Lahore 6
Lappeenranta 6
Las Vegas 6
Mexico City 6
Miami 6
Newark 6
Totale 5.509
Salva come PNG Salva come JPEG
Nome #
Quality of Life and Cognitive function in pediatric and young adults multiple sclerosis: a cross-sectional study 238
Insulin Sensitivity and Early-Phase Insulin Secretion in Normoglycemic Huntington's Disease Patients 225
Uric acid: a potential biomarker of multiple sclerosis and of its disability 212
Cognitive decline in Huntington's disease expansion gene carriers 208
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 195
Multiple cranial neuropathy due to varicella zoster virus reactivation without vesicular rash: a challenging diagnosis 192
Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study 189
Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study 187
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 176
Closing-in Phenomenon in Huntington's Disease: A Neuropsychological Marker of Frontal/Executive Dysfunction 174
Modifications of resting state networks in spinocerebellar ataxia type 2 173
Cognitive impairment at diagnosis predicts 10-year multiple sclerosis progression 169
Validation of an iPad version of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) 167
Prevalence and features of headache in Parkinson's disease: the role of dopamine 166
NMDA receptor gene variations as modifiers in Huntington disease: a replication study. 163
Prevalence and features of non-motor symptoms in Wilson's disease 163
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion. 153
Default-Mode Network Changes in Huntington's Disease: An Integrated MRI Study of Functional Connectivity and Morphometry. 153
Suicidal ideation in a European Huntington's disease population. 153
Post-mortem diagnosis of invasive pulmonary aspergillosis after alemtuzumab treatment for multiple sclerosis 153
Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease? 151
Dural sinus collapsibility, idiopathic intracranial hypertension, and the pathogenesis of chronic migraine 151
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C 150
How many injections did you miss last month? A simple question to predict interferon β-1a adherence in multiple sclerosis 150
The C-Terminal Cross-linked Telopeptide of Type I Collagen (CTX-I) as a Potential Cardiomyopathy Biomarker in Friedreich Ataxia Patients 149
Cognitive trajectories in multiple sclerosis: a long-term follow-up study 149
CD4/CD8 ratio during natalizumab treatment in multiple sclerosis patients 148
A real-world study of alemtuzumab in a cohort of Italian patients 147
Quality of life and cognitive function in pediatric and young multiple sclerosis patients: a cross-sectional study 145
Cerebellar lobule atrophy and disability in progressive MS 144
Uric acid in relapsing–remitting multiple sclerosis: a 2-year longitudinal study 143
Anti-calcitonin gene-related peptide monoclonal antibodies for the treatment of vestibular migraine: A prospective observational cohort study 142
A head-to-head observational cohort study on the efficacy and safety of monoclonal antibodies against calcitonin gene-related peptide for chronic and episodic migraine 138
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 138
A randomized clinical trial of lithium in multiple system atrophy. 135
Ocrelizumab depletes T-lymphocytes more than rituximab in multiple sclerosis 135
Update on infective complications in patients treated with alemtuzumab for multiple sclerosis: review and meta-analysis of real-world and randomized studies 135
Mobitz type I and II atrioventricular blocks during fingolimod therapy 134
A snapshot on patient-reported outcome measures of people with multiple sclerosis on first-line therapies in a real world setting 134
Predictors of Nabiximols (Sativex®) discontinuation over long-term follow-up: a real-life study 134
The putative role of trigemino-vascular system in brain perfusion homeostasis and the significance of the migraine attack 132
Interplay Between Cognitive and Bowel/Bladder Function in Multiple Sclerosis 132
Bacterial and CMV pneumonia in a patient treated with alemtuzumab for multiple sclerosis 131
Recurrent reflex syncope in idiopathic intracranial hypertension patient resolved after lumbar puncture: pathogenetic implications 127
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and orientation tests 126
Integration of the expanded disability status scale with ambulation, visual and cognitive tests 124
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. 123
Cerebellum and cognition in progressive MS patients: functional changes beyond atrophy? 123
Observing Huntington's disease: the European Huntington's Disease Network's REGISTRY. 122
Olfactory function and cognition in relapsing–remitting and secondary-progressive multiple sclerosis 122
Comprehensive Evaluation of Plasma 7-Ketocholesterol and Cholestan-3β,5α,6β-Triol in an Italian Cohort of Patients Affected by Niemann-Pick Disease due to NPC1 and SMPD1 Mutations 121
Molecular Genetics of Niemann-Pick Type C Disease in Italy: An Update on 105 Patients and Description of 18 NPC1 Novel Variants 121
A Novel PSEN1 Mutation in a Patient with Sporadic Early-Onset Alzheimer's Disease and Prominent Cerebellar Ataxia. 120
A longitudinal real-life comparison study of natalizumab and fingolimod 116
Outcomes after fingolimod to alemtuzumab treatment shift in relapsing–remitting MS patients: a multicentre cohort study 116
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 115
Clinical manifestations of intermediate allele carriers in Huntington disease 115
Pulse pressure and presence of coronary artery calcification 114
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis 114
A 8-year retrospective cohort study comparing Interferon-beta formulations for relapsing-remitting multiple sclerosis 111
A 8-year retrospective cohort study comparing Interferon-β formulations for relapsing-remitting multiple sclerosis 111
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 108
Clinical predictors of Dimethyl Fumarate response in multiple sclerosis: a real life multicentre study 108
The Framingham cardiovascular risk score in multiple sclerosis 97
Incidence and predictive risk factors of infective events in patients with multiple sclerosis treated with agents targeting CD20 and CD52 surface antigens 97
Are anti-calcitonin gene-related peptide monoclonal antibodies effective in treating migraine aura? A pilot prospective observational cohort study 91
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 85
Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis 84
Cardiovascular profile improvement during Natalizumab treatment 81
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 81
Lifestyle and Mediterranean diet adherence in a cohort of Southern Italian patients with Multiple Sclerosis 78
Healthcare Costs for Treating Relapsing Multiple Sclerosis and the Risk of Progression: A Retrospective Italian Cohort Study from 2001 to 2015 78
Pregnancy outcomes in alemtuzumab treated women with multiple sclerosis: a case series 77
Therapeutic lag in reducing disability progression in relapsing-remitting multiple sclerosis: 8-year follow-up of two randomized add-on trials with atorvastatin 74
CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion 67
Growth hormone/IGF-1 axis longitudinal evaluation in clinically isolated syndrome patients on interferon β-1b therapy: stimulation tests and correlations with clinical and radiological conversion to multiple sclerosis 61
Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study 58
Assessment of the Performance of a Modified Motor Scale as Applied to Juvenile Onset Huntington's Disease 56
Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series 51
null 45
β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease 45
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 14
BK polyomavirus-associated progressive multifocal leukoencephalopathy following mogamulizumab therapy for erythrodermic mycosis fungoides 12
Totale 10.545
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.918
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022415 0 0 9 4 11 24 8 21 55 37 99 147
2022/2023698 67 66 19 35 77 80 19 63 102 116 37 17
2023/2024497 25 73 45 32 28 51 49 66 7 10 78 33
2024/20252.548 100 128 20 31 79 155 304 175 114 312 927 203
2025/20264.997 532 345 521 514 922 191 592 230 573 352 130 95
2026/2027547 203 207 137 0 0 0 0 0 0 0 0 0
Totale 10.545